Autoimmune Diseases Clinical Trials
18 studies are recruiting for autoimmune diseases in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
Deciphering the Genetic Architecture of Autoimmune Diseases
Background: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and South America. Research…
- Stage
- Not phased
- Ages
- 18 to 115
- Site
- Amazon Rainforest, Lima,
- Locations
- 2 in total
- Run by
- National Human Genome Research Institute (NHGRI)
-
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
The study is a randomized, double-blind, parallel-group clinical trial to examine the effects of 24 weeks of oral AMX0035 (sodium phenylbutyrate + taurursodiol) versus placebo in 60 adults with Type 1 Diabetes (T1D) (n=30 per arm). Enrollment will be distributed equally between the University of Wa…
- Stage
- Phase 2
- Ages
- 18 to 69
- Site
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle, Washington
- Locations
- 2 in total
- Run by
- University of Washington
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects with unstable Type 1 D…
- Stage
- Phase 1
- Ages
- 35 to 70
- Site
- University of Illinois Hospital & Health Sciences System, Chicago, Illinois
- Run by
- Otsuka Pharmaceutical Factory, Inc.
-
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Multiple sclerosis (MS) rates in the U.S. have nearly doubled over the past decade, making it a leading cause of nontraumatic functional impairment in young adults and significantly affecting cognitive function in up to 70% of people with MS. While traditional cognitive rehabilitation methods are l…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- University of Texas at Austin, Austin, Texas
- Run by
- University of Texas at Austin
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 142 in total
- Run by
- Center for International Blood and Marrow Transplant Research
-
Testimonials and Navigation in Rheumatology
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 3 in total
- Run by
- University of Alabama at Birmingham
-
Ovarian Tissue Cryopreservation for Fertility Preservation
The goal of this observational study is to learn about fertility preservation for pre-pubertal, peri-pubertal, and adult participants that are unable to pursue clinical standard of care fertility preservation such as egg (oocyte) and embryo cryopreservation. In addition, this study will provide res…
- Stage
- Not phased
- Ages
- Up to 39
- Site
- Magee-Womens Hospital, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
-
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG). Anitocabtagene autoleucel (anito-cel) is a BCMA-directed CAR-T cell therapy.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- UCLA Medical Center, Los Angeles, California
- Locations
- 13 in total
- Run by
- Arcellx, Inc.
-
Biologics And Clinical Immunology Cohort at Sinai
The study team plans to establish a bioregistry of patients receiving biologic therapy as part of their standard treatment at the Mount Sinai Therapeutic Infusion Center and affiliated practices. The study team will to apply state-of-the-art approaches to assessing and predicting immunological and …
- Stage
- Not phased
- Ages
- 12 and older
- Site
- Mount Sinai, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
-
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years…
- Stage
- Not phased
- Ages
- 2 and older
- Site
- Brain Inflammation Collaborative, Delafield, Wisconsin
- Run by
- Brain Inflammation Collaborative
-
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy. Prior studies demonstrate the importance…
- Stage
- Not phased
- Ages
- Any age
- Site
- Duke University, Durham, North Carolina
- Run by
- Duke University
-
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Single-site, open label pilot study of 20 autoimmune patients diagnosed with dry eye demonstrating via the proparacaine challenge some peripheral corneal pain component. At least 16 patients will receive and complete 12 weeks of 80 units of Acthar Gel to be injected subcutaneously twice weekly via …
- Stage
- Phase 4
- Ages
- 18 to 85
- Site
- Toyos Clinic, Nashville, Tennessee
- Run by
- Toyos Clinic
-
X-linked Moesin Associated Immunodeficiency
Moesin deficiency was initially described in 7 male participants aged 4 to 69 years and is characterized by lymphopenia of the 3 lineages and moderate neutropenia. Genetically, 6 out of 7 participants had the same missense mutation in the moesin gene located on the X chromosome. The 7th patient has…
- Stage
- Not phased
- Ages
- 4 to 80
- Site
- Hôpital Necker, Paris, PARIS
- Locations
- 10 in total
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
-
Rheumatology Diet Study
This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on their dietary habits and how it affects their autoimmune disease. The main objective is to see if rheumatology patients cha…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- UCF Health Clinics, Orlando, Florida
- Run by
- University of Central Florida
-
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
Vagal nerve stimulation is a neurosurgical procedure consisting of implantation of an impulse generator battery with leads placed into the vagus nerve in the neck. This procedure was FDA approved for epilepsy in the 1990s and is commonly performed as an outpatient surgery. The mechanism of action i…
- Stage
- Not phased
- Ages
- 0 to 60
- Site
- University of Louisville, Louisville, Kentucky
- Locations
- 4 in total
- Run by
- University of Louisville
-
IMPACT - AndHealth Autoimmune Research Registry
This is a patient research registry aimed at evaluating the effectiveness of a comprehensive, root-cause medical approach ("AndHealth program") for autoimmune disorders. This approach involves a combination of pharmacological and non-pharmacological therapies offered under the care of a licensed ph…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- AndHealth, Columbus, Ohio
- Run by
- AndHealth
-
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagno…
- Stage
- Not phased
- Ages
- 0 to 89
- Site
- iSpecimen, Huntsville, Alabama
- Locations
- 2 in total
- Run by
- iSpecimen Inc
-
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective fo…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California
- Run by
- Thomas Advanced Medical LLC
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.